GLP-1 Drugs Increase Risk of Acid Reflux, GERD, Study Finds

GLP-1 drugs increase risk of acid reflux, GERD, study finds

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new Canadian study reported Tuesday.

Diabetes patients on Ozempic-like drugs more likely to develop gastroesophageal reflux disease

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors on the risk for gastroesophageal reflux disease (GERD) and its complications in patients with type 2 diabetes.

Nordic Cold Chain Solutions Unveils First Packaging System Tailored for GLP-1 Drug Shipments

HATFIELD, PA — Nordic Cold Chain Solutions has introduced the Nordic Express Pack, a first-of-its-kind packaging system engineered specifically for the shipment of GLP-1 medications, marking a significant advancement in cold chain logistics for the pharmaceutical industry. GLP-1 drugs, widely used in diabetes and weight management therapies, require strict temperature control throughout the shipping process to preserve their efficacy and meet re…

GLP-1s patients more likely to develop GERD

The incidence of gastroesophageal reflux disease (GERD) is higher among people taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with those taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors, according to researchers from McGill University and Lady Davis Institute, Jewish General Hospital in Montreal, Canada.The researchers designed a population-based cohort study emulating a target trial that estimated the effect of G…